DNAJC5 and malaria: To varying degrees, we observed reduced hazards of homologous reinfection for each epitope type within each prevalence stratum, with the lowest hazards for homologous reinfection associated with symptomatic malaria observed for the rare CSP-Th2R (aHR 0.35, 95% CI 0.16–0.77, p = 0.010) and AMA-1 c1L (aHR 0.23, 95% CI 0.08–0.68, p = 0.008) epitope types.